[1] 徐小元,丁惠国,李文刚,等.肝硬化诊治指南.实用肝脏病杂志,2019,22(06):770-786.
[2] 陆伦根,尤红,谢渭芬,等.肝纤维化诊断及治疗共识(2019年).实用肝脏病杂志,2019,22(06):793-803.
[3] Sun M,Kisseleva T.Reversibility of liver fibrosis.Clin Res Hepatol Gastroenterol,2015,39 Suppl 1(0 1):S60-S63.
[4] Regev A,Berho M,Jeffers LJ,et al.Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.Am J Gastroenterol,2002,97(10):2614-2618.
[5] D’Amico G,Morabito A,D’Amico M,et al.Clinical states of cirrhosis and competing risks.J Hepatol,2018,68:563–576.
[6] Asrani SK,Devarbhavi H,Eaton J,et al.Burden of liver diseases in the world.J Hepatol,2019,70(1):151-171.
[7] Angermueller C,Pärnamaa T,Parts L,et al.Deep learning for computational biology.Mol Syst Biol,2016,12(7):878.
[8] Dinani AM,Kowdley KV,Noureddin M.Application of artificial intelligence for diagnosis and risk stratification in NAFLD and NASH:The state of the art.Hepatology,2021,74(4):2233-2240.
[9] Wei R,Wang J,Wang X,et al.Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning.EBioMedicine,2018,35:124-132.
[10] 陈洁,张波.超声定量评估非酒精性脂肪肝病肝脏脂肪变性的研究进展.中国医学科学院学报,2021,43(05):827-832.
[11] Okanoue T,Shima T,Mitsumoto Y,et al.Artificial intelligence/neural network system for the screening of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Hepatol Res,2021,51(5):554-569.
[12] Okanoue T,Shima T,Mitsumoto Y,et al.Novel artificial intelligent/neural network system for staging of nonalcoholic steatohepatitis.Hepatol Res,2021,51(10):1044-1057.
[13] Lambin P,RiosVelazquez E,Leijenaar R,et al.Radiomics:extracting more information from medical images using advanced feature analysis. Eur J Cancer,2012,48(4):441446.
[14] 陈琦,冯露漪,贺松,等.人工智能技术在影像组学中的应用.数字化用户,2019,25(46):129,135.
[15] Li J,Qureshi M,Gupta A,et al.Quantification of degree of liver fibrosis using fibrosis area fraction based on statistical chi-square analysis of heterogeneity of liver tissue texture on routine ultrasound images.Acad Radiol,2019,26(8):1001-1007.
[16] Wang JC,Fu R,Tao XW,et al.A radiomics-based model on non-contrast CT for predicting cirrhosis:make the most of image data.Biomark Res, 2020,8:47.
[17] Park HJ,Lee SS,Park B,et al.Radiomics analysis of gadoxetic acid-enhanced MRI for staging liver fibrosis.Radiology, 2019,290(2):380-387.
[18] Nitsch J,Sack J,Halle MW,et al.MRI-based radiomic feature analysis of end-stage liver disease for severity stratification.Int J Comput Assist Radiol Surg,2021,16(3):457-466.
[19] Wong RJ,Gish RG,Ahmed A.Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.Liver Transpl,2014,20(12):1454-1461.
[20] Cao JM,Yang JQ,Ming ZQ,et al.A radiomics model of liver CT to predict risk of hepatic encephalopathy secondary to hepatitis B related cirrhosis.Eur J Radiol,2020,130:109201.
[21] Jakab SS,Garcia-Tsao G.Evaluation and management of esophageal and gastric varices in patients with cirrhosis.Clin Liver Dis, 2020,24(3):335-350.
[22] Amitrano L,Guardascione MA,Manguso F,et al.The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors.Am J Gastroenterol, 2012,107(12):1872-1878.
[23] Reiberger T,Püspök A,Schoder M,et al.Austrian consensus guidelines on the management and treatment of portal hypertension (BillrothIII).Wien Klin Wochenschr,2017,129(Suppl 3):135-158.
[24] De Franchis R,Baveno VI, Faculty.Expanding consensus in portal hypertension: report of the baveno vi consensus workshop:stratifying risk and individualizing care for portal hypertension.J Hepatol, 2015,63(3):743-752.
[25] Lin Y,Li L,Yu D,et al.A novel radiomics-platelet nomogram for the prediction of gastroesophageal varices needing treatment in cirrhotic patients.Hepatol Int,2021,15(4):995-1005. |
